CARCINOMA IN SITU OF BLADDER
Clinical trials for CARCINOMA IN SITU OF BLADDER explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA IN SITU OF BLADDER trials appear
Sign up with your email to follow new studies for CARCINOMA IN SITU OF BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Virus-Based therapy offered to bladder cancer patients who failed standard care
Disease control AVAILABLEThis program provides early access to cretostimogene grenadenorepvec, a virus-based therapy, for patients with non-muscle invasive bladder cancer that has not responded to standard BCG treatment. Eligible participants have a specific type of bladder cancer (CIS with or without hi…
Matched conditions: CARCINOMA IN SITU OF BLADDER
Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug combo aims to control bladder cancer when standard therapy fails
Disease control Recruiting nowThis study tests two drugs, durvalumab and monalizumab, given together to people with a type of bladder cancer that has not gotten better with standard treatment. The goal is to see if the combination can make the cancer disappear or stop it from growing. About 60 adults will tak…
Matched conditions: CARCINOMA IN SITU OF BLADDER
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Engineered TB bacteria could offer new hope for bladder cancer patients
Disease control Recruiting nowThis early-stage trial is testing a new version of the BCG therapy, made from a genetically modified bacterium, for people with non-muscle invasive bladder cancer (NMIBC) who have not received BCG before. The treatment is given directly into the bladder through a catheter. The st…
Matched conditions: CARCINOMA IN SITU OF BLADDER
Phase: PHASE1, PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC